• Applied Workflows with EZ Cap Cy5 Firefly Luciferase mRNA

  2026-06-19

  EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) enables dual-mode, high-resolution tracking of mRNA delivery and expression in real time. With improved translation and reduced immunogenicity, it sets a new standard for optimizing transfection and imaging workflows across cell and tissue models.

• Ibrexafungerp’s Activity Against Echinocandin-Resistant Cand

  2026-06-19

  This study rigorously assesses ibrexafungerp (MK 3118) in vitro efficacy against a comprehensive set of echinocandin-resistant Candida isolates, emphasizing its activity across specific FKS gene mutation hotspots. The findings provide critical insights for antifungal stewardship and highlight the nuanced susceptibility landscape relevant to resistant invasive candidiasis.

• HATU in Peptide Synthesis Chemistry: Protocols and Solutions

  2026-06-18

  HATU revolutionizes peptide synthesis chemistry by offering rapid, high-yield amide and ester formation, especially in complex inhibitor design. This guide translates cutting-edge reference findings and proven protocols into actionable workflows and troubleshooting tactics for researchers demanding precision and reproducibility.

• Dehydroepiandrosterone (DHEA): Optimizing Neuroprotection &

  2026-06-18

  Dehydroepiandrosterone (DHEA) empowers advanced workflows in neuroprotection and ovarian biology, offering precise control over apoptosis inhibition and granulosa cell proliferation. This guide details best practices, troubleshooting, and evidence-driven protocol enhancements to maximize translational and mechanistic research impact.

• Telomere Targeting Sensitizes Latent HIV-1 Reservoirs to Apo

  2026-06-17

  This study reveals that latent HIV-1 infection in CD4+ memory T cells leads to telomere elongation, which enhances the cells’ resistance to elimination. The authors demonstrate that agents targeting telomeres or the DNA damage response preferentially induce apoptosis in these latent reservoirs, offering new avenues for HIV cure strategies.

• Biomimetic Chromatography for Pulmonary Drug Permeability Mo

  2026-06-17

  This study systematically compares immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) as biomimetic methods for predicting drug partitioning and permeability across the respiratory mucosa. The findings clarify each technique's predictive capabilities, highlighting LEKC's superior modeling of pulmonary drug transport and IAM LC's broader chemical compatibility, offering new guidance for early-phase antiretroviral and permeability-focused drug research.

• Fangchinoline Restores TFEB-Driven Lysosomal Biogenesis to C

  2026-06-16

  This study identifies fangchinoline as a potent modulator of lysosomal biogenesis via TFEB activation, effectively blocking H1N1 influenza entry and replication. The findings highlight the potential of targeting host lysosomal pathways for antiviral intervention and provide a mechanistic foundation for future lysosome-directed therapeutic strategies.

• Dimetridazole as a Quorum Sensing Inhibitor in P. aeruginosa

  2026-06-16

  Yuan et al. (2022) demonstrated that Dimetridazole, a 1,2-dimethyl-5-nitroimidazole compound, can suppress Pseudomonas aeruginosa virulence by targeting its quorum sensing systems rather than by direct antimicrobial activity. This antivirulence approach offers a promising strategy to mitigate infection and antibiotic resistance development, with implications for drug repurposing in antimicrobial research.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP): Precision Tracking and Tran

  2026-06-15

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) enables precise, real-time quantification of mRNA delivery and translation efficiency. This article reveals new assay strategies and scientific insights, distinguishing itself by integrating lessons from advanced nanoparticle delivery research.

• TMEM16F in Kupffer Cells Restricts Listeria-Driven Liver Dam

  2026-06-15

  This study demonstrates that TMEM16F expression in liver Kupffer cells is essential for protection against Listeria monocytogenes by preserving plasma membrane integrity and regulating inflammation. These findings clarify cell-type-specific immune mechanisms and open new avenues for dissecting inflammatory responses in infectious disease models.

• Cy3 TSA Fluorescence System Kit: Amplifying Detection in IHC

  2026-06-14

  The Cy3 TSA Fluorescence System Kit delivers ultrasensitive detection for immunohistochemistry, immunocytochemistry, and in situ hybridization by leveraging tyramide signal amplification. Explore how this system enables the visualization of low-abundance targets, optimizes workflows, and addresses common pitfalls in advanced molecular research.

• Lanabecestat (AZD3293): Precision BACE1 Inhibition in Alzhei

  2026-06-13

  Lanabecestat (AZD3293) is a potent, orally active BACE1 inhibitor used in Alzheimer's disease research. It achieves up to 50% reduction in amyloid-beta production without disrupting synaptic transmission, according to recent peer-reviewed studies. This compound supports targeted modulation of the amyloidogenic pathway and is available from APExBIO for preclinical workflows.

• Rapamycin (Sirolimus): mTOR Inhibition, Evidence & Protocols

  2026-06-12

  Rapamycin (Sirolimus) is a validated, nanomolar-potency mTOR inhibitor that modulates pivotal cell signaling pathways, making it central to research in cancer, immunology, and mitochondrial diseases. APExBIO’s A8167 product offers reproducible inhibition of mTOR, ERK, and JAK2/STAT3 signaling, as confirmed by peer-reviewed evidence and workflow best practices.

• CGF Induces ROS-Mediated Cell Cycle Arrest in Colorectal Can

  2026-06-12

  This article examines how the natural compound CGF disrupts colorectal cancer progression by driving ROS-mediated metabolic reprogramming and mitochondrial dysfunction. The study reveals that CGF impairs ABC transporter function, causes ATP accumulation, and induces apoptosis and cell cycle arrest, highlighting a promising avenue for therapeutic development.

• SB743921 and the Evolving Science of Cell Cycle Arrest in Ca

  2026-06-11

  Explore how SB743921, a potent kinesin spindle protein inhibitor, is redefining cell cycle arrest strategies in cancer research. This article uniquely bridges mechanistic depth with assay optimization, drawing on the latest scientific insights.

16503 records 1/1101 page Next 12345 下5页 Last page